25.50 USD
▼-0.76-2.89%
盘后 29.30 0.00%
2026-09-15
市值
$241.91M
市盈率
—
EPS
-66.82
股息率
—
52 周区间
14.68 – 46.95
成交量
80.27K
Beta
2.07
目标价
57.00
52W 低 14.6852W 高 46.95
价格走势
公司简介
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company’s candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves’ disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.